Iovance Biotherapeutics Stock Technical Analysis
IOVA Stock | USD 10.33 0.01 0.1% |
As of the 23rd of May, Iovance Biotherapeutics retains the market risk adjusted performance of (0.02), and Standard Deviation of 5.57. Iovance Biotherapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Iovance Biotherapeutics, which can be compared to its competitors. Please check out Iovance Biotherapeutics standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Iovance Biotherapeutics is priced fairly, providing market reflects its last-minute price of 10.33 per share. Given that Iovance Biotherapeutics has information ratio of (0.03), we strongly advise you to confirm Iovance Biotherapeutics's regular market performance to make sure the company can sustain itself at a future point.
Iovance Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Iovance, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IovanceIovance |
Iovance Biotherapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
22.36 | Strong Buy | 14 | Odds |
Most Iovance analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Iovance stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Iovance Biotherapeutics, talking to its executives and customers, or listening to Iovance conference calls.
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Iovance Biotherapeutics Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Iovance Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Iovance Biotherapeutics Trend Analysis
Use this graph to draw trend lines for Iovance Biotherapeutics. You can use it to identify possible trend reversals for Iovance Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Iovance Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Iovance Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Iovance Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.1 , which may suggest that Iovance Biotherapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 357.43, which is the sum of squared deviations for the predicted Iovance Biotherapeutics price change compared to its average price change.About Iovance Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Iovance Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Iovance Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Iovance Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Iovance Biotherapeutics. By analyzing Iovance Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Iovance Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Iovance Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Payables Turnover | 1.0 | 0.95 | Days Of Inventory On Hand | 102.85 | 91.42 |
Iovance Biotherapeutics May 23, 2024 Technical Indicators
Most technical analysis of Iovance help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iovance from various momentum indicators to cycle indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Market Risk Adjusted Performance | (0.02) | |||
Mean Deviation | 3.3 | |||
Coefficient Of Variation | (6,427) | |||
Standard Deviation | 5.57 | |||
Variance | 31.01 | |||
Information Ratio | (0.03) | |||
Jensen Alpha | (0.29) | |||
Total Risk Alpha | (0.76) | |||
Treynor Ratio | (0.03) | |||
Maximum Drawdown | 49.53 | |||
Value At Risk | (5.54) | |||
Potential Upside | 5.82 | |||
Skewness | 2.23 | |||
Kurtosis | 15.79 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Iovance Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Revenue Per Share 0.008 | Return On Assets (0.34) | Return On Equity (0.67) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.